AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Transcutaneous Auricular Vagus Nerve Stimulation Added to Physiotherapy for Adhesive Capsulitis

RecruitingNAAges 18 Years - 65 YearsAllMuhsin Doran
💬

In plain words

What the trial is, and whether it could suit you

This randomized, sham-controlled study will evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS), when added to standard physiotherapy, improves pain, shoulder function, range of motion, and quality of life in adults with adhesive capsulitis. A total of 40 participants aged 18 to 65 years will be randomly assigned to one of two groups. Both groups will receive 15 sessions of standard physiotherapy over 3 weeks. In addition, one group will receive active taVNS for 30 minutes per day, while the other group will receive sham stimulation for the same duration and frequency. Assessments will be performed before treatment and after the 15th treatment session using pain, shoulder disability, quality-of-life, and shoulder range-of-motion measurements.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 65 years. * Clinical diagnosis of adhesive capsulitis confirmed by physical examination and, when clinically indicated, imaging. * Shoulder pain and limitation of shoulder range of motion for at least 3 months. * Provision of written informed consent. * General health status sufficient to participate in standard physiotherapy and active or sham transcutaneous auricular vagus nerve stimulation. * Ability to comply with the planned treatment sessions and outcome assessments. Exclusion Criteria: * Shoulder stiffness secondary to trauma, surgery, infection, or tumor. * Rotator cuff tear, advanced glenohumeral osteoarthritis, or inflammatory rheumatic disease. * Glucocorticoid injection into the affected shoulder within the previous 3 months. * Surgical intervention involving the affected shoulder within the previous 6 months. * Active infection or skin lesion in the shoulder region. * Cervical radiculopathy, brachial plexopathy, stroke, or another neurological disorder affecting the upper extremity. * Presence of a cardiac pacemaker or another implanted electronic device. * Pregnancy or breastfeeding. * Serious systemic disease or cognitive impairment that may prevent compliance with the study protocol. * Known intolerance or previous adverse reaction to transcutaneous electrical stimulation.
💊

What it tests

  • Active Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
  • Conventional Physiotherapy
  • Sham Transcutaneous Auricular Vagus Nerve Stimulation
📍

Where

1 site
Liv hospital Vadistanbul
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy